SYNOPSIS Two criteria which ought to be satisfied by an acceptable method for the estimation of serum transferrin by iron-binding capacity are enunciated. A screening procedure is described which involves the sequential quantitative use of ion exchange and gel filtration. Its use in testing the extent to which two published methods fulfil the recommended criteria is described. Both methods give results for total iron-binding capacity which are 1-10 % high because of the inclusion of non-transferrin iron.
Serum iron-binding capacity is usually measured by adding an excess of iron and measuring the iron retained after the action of a suitable reagent, such as light magnesium carbonate (Ramsay, 1957; Brozovich, 1968) , an ion exchange resin (Peters, Giovanniello, Apt, and Ross, 1956;  Charlton, Hardie, and Bothwell, 1965) , charcoal coated with haemoglobin (Herbert, Gottlieb, Lau, Fisher, Gevirtz, and Wasserman, 1966) , or Sephadex G-25 after treatment of the iron-enriched serum with 1,10-phenanthroline and Na2S204 (Nielsen, 1968) . Iron forms a wide range of covalent complexes which might escape removal by one or other of these reagents, but broad agreement among the methods and the exceptional stability of the iron transferrin complex in slightly alkaline solution give some support for the belief that iron-binding capacity gives an estimate of serum transferrin. If the final analysis is chemical, the result includes the original serum iron and gives the total iron-binding capacity (TIBC) . If the added iron is radioactive, the retained radioactivity gives unsaturated ironbinding capacity (UIBC). Total iron-binding capacity should thus correspond to the total serum transferrin and UIBC to that proportion of which the binding sites are not already occupied by the serum iron. If the experimental conditions permit exchange between the original serum iron and the radioactive iron, a falsely high UIBC figure will result. That this does not commonly happen is confirmed by the fact that the theoretical equation TIBC = serum Fe + UIBC is usually experimentally satisfied within narrow limits.
Received for publication 5 July 1973. Bothwell, Conrad, Cook, Fielding, Hallberg, Izak, Layrisse, and Ramsay (1972) have, however, pointed out that all current iron-binding capacity methods are empirical. Several of the original workers showed that transferrin behaved in the expected way and some tested the effects of possible interfering substances such as citrate or oxalate, but the possibility was never excluded that some of the iron finally measured might not be specifically bound to transferrin. Ramsay (1957) cautioned that magnesium carbonate preparations should be tested before use. Leggate and Crooks (1972) have reported differences in the behaviour of fresh and preserved or lyophilized serum. In their search for suitable standard reference materials and methods Bothwell et al (1972) found wide variations in the analysis of preserved specimens. Williams and Conrad (1972) , in an examination of the magnesium carbonate method, found that the use of a barbitone buffer affected the determination of IBC in fresh serum. The electrophoretic investigation of magnesium carbonate supernatants (van der Heul, van Eijk, Wiltink, and Leijnse, 1972) suggested that up to 20% of UIBC might represent iron bound to proteins other than transferrin, largely albumin and gamma globulin.
There is thus a clear need for critical evaluation of the specificity of iron-binding capacity methods. In theory, a reliable method ought to satisfy two criteria: (1) all the iron retained after removal of the excess should be demonstrably bound to transferrin, and (2) the iron so bound should be the maximum which can be held by the transferrin present. This paper describes a generally applicable procedure which gives definite if not fully conclusive 691 evidence on the first point and can be adapted to give some information on the second.
Preliminary experiments showed that gel filtration of a magnesium carbonate supernatant gave a single smooth peak of 56Fe with a maximum corresponding apparently to a molecular weight slightly higher than that of albumin, of which the elution peak was judged by absorbance at 280 nm. Recovery of the 59Fe, however, was not complete:
2-8 % of the radioactivity in the magnesium carbonate supernatant adhered firmly to the column and could only be easily eluted with citric acid. This was believed to represent iron bound loosely, perhaps to other proteins, and detached in the course of passage through the Sephadex column. That it was not an artefact of gel filtration was proved by rechromatography of the peak containing most of the 59Fe, when complete recovery in the same molecular weight range was found. These observations were consistent with the accepted view that most of the iron in a magnesium carbonate supernatant is transferrin. They did not exclude the possibility that some proportion of the iron might be bound to a protein of somewhat similar molecular weight, such as albumin. Gel filtration was therefore preceded by an ion exchange fractionation which separates transferrin completely from albumin. Transferrin passes readily through a column of DEAE-Sephadex at pH 8-0-8-5 at an ionic strength of 015 but albumin is strongly retarded unless the ionic strength is substantially increased. These procedures have been combined in a two-stage analysis which is illustrated in figure 1 . It gives quantitative identification of the iron in a magnesium carbonate supernatant ( Commercial human transferrin (Behringwerke) was chromatographed before use on Sephadex G-150. Only the peak fractions comprising about half the material were used. Radioactive iron solutions were prepared from 69FeC13 in HCI (Radiochemical Centre, Amersham, Bucks). Other reagents were of analytical reagent quality.
IRON-BINDING CAPACITY METHODS
The MgCO3 method was used in the way described by Bothwell et al(1972) ,except that the recommended amount of saturating radioiron was added in a volume equal to that of the serum. Nielsen (1968) separated the serum proteins, including transferrin, from excess iron after allowing the latter to complex with 1,10-phenanthroline in the presence ofNa2S204. lHe used Sephadex G-25 in a column of special design, but good separations are made in this laboratory on columns of fully 10 ml bed volume in 10-ml syringes. Sephadex G-25 is suspended in NaCl (0-14 M) containing HCI (0-01 M) and tris (hydroxymethyl) amino methane (0-025 M). After the addition of the reagents to serum as described by Nielsen (1968) , the mixture (1 ml) is pipetted slowly onto the surface of the column. The flow rate is adjusted to 4-5 ml/hr. When the serum just disappears completely into the Sephadex bed, salt-tris solution is pipetted carefully on to the surface as required. The initial The measurement of serum transferrin by iron-binding capptity eluate (3 ml) is discarded and the next portion is collected in a tube accurately marked at 4 ml, which should contain all the serum proteins and hence all the transferrin-bound iron. It can be used for radioactive assay and chemical estimation of iron or for the subsequent fractionation on DEAE-Sephadex. After each run residual iron is flushed from the column with 4-5 ml NaCl (0-15 M) containing citric acid (0-05 M) followed by 20 ml salt-tris.
DEAE-SEPHADEX A-50
Columns of 1P5 to 1P7 ml settled bed volume were prepared in 2 ml syringes using DEAE-Sephadex A-50 equilibrated with and suspended in NaCl (0-14 M) containing HCl (0-01 M) and tris (0-025 M). The solution to be fractionated should be at pH 8-9 and the ionic strength should be 0-13-0 15. The Nielsen eluate described is suitable for immediate use, but the MgCO3 supernatant requires the addition of a small calculated volume ofconcentrated NaCl (eg, 0 03 ml 2 N NaCl per ml MgCO3 supernatant).
A prepared column is allowed to drain under gravity and placed over a clean, dry tube marked at 4 ml. Up to 15 ml of a suitable solution is measured accurately onto the surface. The flow rate is adjusted to 4-5 ml/hr, and the liquid is allowed to pass completely into the bed. Small volumes of salt-tris (up to 1 ml) are added successively, allowing complete drainage after each addition, until the volume of eluate reaches 4 ml. The eluate is assayed for radioactivity and iron or may be used for analysis on Sephadex G-150. Columns prepared in NaCl (0-5 M) containing tris-HCl (0-02 M; pH 8 5) and sodium azide (0-2%) 0 0 are run by upward flow with the same solution at 1P2-1P5 ml cm-2 hr1. Samples of 1 to 4 ml are applied by gravity flow through a T-junction and fractions of up to 3 ml collected as required. The larger volumes do not give maximum fractionation on columns of the size used, but experiment showed that for routine purposes no detectable error was introduced. After each run residual iron is removed by flushing the column with 10-12 ml salt-citric acid.
ELECTROPHORESIS
Electrophoresis is carried out in 7-5 % polyacrylamide gel in the discontinuous tris-glycine buffer system (pH 8-5) of Davis (1964) . Gels are stained with naphthalene black and scanned in a Gilford scanner at 600 nm.
RADIOACTIVITY ASSAY
Radioactivity is assayed in a Gamma guard counter (Tracerlab, GB, Ltd) set to give maximum efficiency for 59Fe. Only in the gel filtration experiments, where some individual fractions gave very low counts, did the standard error of counting exceed 1%.
IRON ESTIMATIONS
Iron is estimated by a method modified slightly from that recommended by the International Committee for Standardization in Hematology (1971). The solution (4 ml) is treated with mixed acid reagent (trichloroacetic acid, 1 8 M; HCI, 0-8 M; thioglycollic acid, 0 5 M; I ml), mixed thoroughly and centrifuged to obtain a clear supernatant. The supernatant (4 ml) is treated with the chromogen (disodium diphenylphenanthroline disulphonate, 0 04 %, in sodium acetate, 3 M; 1 ml) and the absorbance of the stable pink complex is Migrat ion disE ance, cm measured at 535 nm. The sensitivity of the method can be doubled by using optical cells of light path 20 mm.
Results
The validity of scheme 1 (fig 1) as a quantitative test procedure depends both on freedom from adventitious losses of transferrin-bound iron and on the successful separation of transferrin from albumin. The latter point was investigated by making electrophoretic comparisons of DEAE-Sephadex eluate with serial dilutions of the corresponding original serum. The stained gels were scanned. Figure 2 reproduces the recordings obtained from the DEAE-Sephadex eluate from a normal horse serum and the same serum diluted 125 times. Although a detectable amount of albumin survived the fractionation, this was calculated to be less than 0-5 % of the total. In four other experiments (two horse, two human) the DEAE-Sephadex eluate appeared completely free from albumin. That no transferrin iron is lost on DEAE-Sephadex or Sephadex G-150 under the prescribed conditions is shown by the following results: (1) rechromatography of DEAE-Sephadex eluates on fresh columns of the same reagents (two experiments) gave 99 5 % and 101 % of the applied 59Fe; (2) when purified transferrin (1 mg) was chromatographed on DEAE-Sephadex, E280. measurements gave 99% and 101 % recovery in 4 ml eluate; (3) serum and a sample with added purified transferrin were analysed for UIBC and TIBC by the MgCO3 method. Additional aliquots of MgCO3 supernatant were analysed by the scheme 1 procedure. Table I shows that although the UIBC and TIBC figures for both specimens were lower after the treatment with DEAE-Sephadex, the component attributable to the added transferrin remained unaltered within reasonable limits of experimental error. The UIBC figures in the last two columns of table I confirm that no transferrin was removed by Sephadex G-150.
The results of analyses on Sephadex G-150 of MgCO3 supernatant from (a) fresh serum treated with excess "9Fe, and (b) the corresponding eluate from DEAE-Sephadex are shown in figure 3. The major 59Fe fraction gives a peak at 61 ml in fig 3a and 62-5 in fig 3b, which corresponds in the columns used to a molecular weight slightly higher than that of albumin. The small fraction of 59Fe (a, 2*8 %, b, 0 3 %) eluted only with citric acid, is always very low when a DEAE-Sephadex eluate is run on Sephadex and in about 50 % of analyses is zero. figure 4 , which show that it is removed by DEAESephadex.
Discussion
In the use of scheme 1 it is important to ensure that all transferrin iron is recovered from the ion exchanger, and no generalization, extrapolation, or modification should be made without experimental justification. For example, it has recently been found that sheep transferrin is not completely eluted from the standard size of DEAE-Sephadex column in 4 ml unless the salt concentration of the eluant is raised to a level at which contamination by albumin is difficult to avoid. Again, haemoglobin is not retained on DEAE-Sephadex under the conditions of scheme 1, so it is still necessary to determine iron by methods with which haemoglobin does not interfere.
The results obtained so far show that both the methods tested give iron-binding capacities which include a small non-transferrin component. The MgCO3 method was found by van der Heul et al (1972) , who used different techniques, to have a larger range of error, but this might be explained if they saturated serum specimens with the greater excess of iron originally recommended (Ramsay, 1957) .
Since the Sephadex G-150 analysis removes but little iron from the DEAE-Sephadex eluate, either the MgCO3 method or that of Nielsen (1968) 
